Connor, Clark & Lunn Investment Management (CC&L)’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Connor, Clark & Lunn Investment Management (CC&L)'s EXAS Position: Q1 2026 in Review
Connor, Clark & Lunn Investment Management (CC&L) sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 23,471 shares — an estimated $2.38M sold.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in EXAS in Q1 2023 and held it in 11 quarters. The position peaked at $47M in Q2 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Connor, Clark & Lunn Investment Management (CC&L) sold 23,471 Exact Sciences shares in Q1 2026, an estimated $2.38M.
- Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Exact Sciences in Q1 2023 and held it in 11 quarters.
- Connor, Clark & Lunn Investment Management (CC&L)'s Exact Sciences position peaked at $47M in Q2 2025.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2026, filed 11 May 2026.